Skip to main content
Log in

Evidence-based decision making and health technology assessment

  • Feature Article
  • Published:
Tissue Engineering and Regenerative Medicine Aims and scope

Abstract

In health care, technologies should be diffused and adapted if their safety and efficacy has been established and determined. The role of making such a decision, that is whether the safety and efficacy of a certain technology is established, is encapsulated within the processes of a “health technology assessment (HTA).” In this way, HTA has had a central role in the development of a transient healthcare, which is constantly adapting to meet ever-evolving demands. HTA is a very useful concept and tool for providing information for evidence-based decision making. And evidence-based decision making is critical when resources should be allocated in health care. Therefore, from all interest parties in society, the consensus on the necessity for conducting HTA should be brought. And governments should incorporate results from HTA into policy making as possible as they can.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Office of Technology Assessment, Development of medical technology: opportunities for assessment, Washington DC: U.S. Government Printing Office (1976).

    Google Scholar 

  2. International network of agencies for health technology assessment (http://www.inahta.org), Available at website: accessed March 20, 2013.

  3. D Banta, The development of health technology assessment, Health Policy, 63, 121 (2003).

    Article  PubMed  Google Scholar 

  4. F Sassi, Setting priorities for the evaluation of health interventions: when theory does not meet practice, Health Policy, 63, 141 (2003).

    Article  PubMed  Google Scholar 

  5. SH Park, SM Lee, Evidence-based decision-making and health technology assessment in South Korea, Value in Health, 11, S163 (2008).

    Article  PubMed  Google Scholar 

  6. M Perleth, R Busse, Health technology assessment in Germany. Status, challenges, and development, Int J Technol Assess Health Care, 16, 412 (2000).

    Article  PubMed  CAS  Google Scholar 

  7. W Claudia, G Bernhard, Evaluations of health interventions in social insurance-based countries: Germany, the Netherlands, and Austria, Health Policy, 63, 187 (2003).

    Article  Google Scholar 

  8. O Golan, P Hansen, G Kaplan, et al., Health technology prioritization: which criteria for prioritizing new technologies and what are their relative weights, Health Policy, 102, 126 (2011).

    Article  PubMed  Google Scholar 

  9. I Kamae, Value-based approaches to healthcare systems and pharmacoeconomics requirements in Asia: South Korea, Taiwan, Thailand and Japan, Pharmacoeconomics, 28, 831 (2010).

    Article  PubMed  Google Scholar 

  10. PJ Feldstein, Health Care Economics, Fifth edition, Delmar Publishers: New York (2002).

    Google Scholar 

  11. JE Stiglitz, CE Walsh, Economics, Third edition, W. W. Norton & Company Ltd: London (2002).

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Eun-Hwan Oh.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Oh, EH. Evidence-based decision making and health technology assessment. Tissue Eng Regen Med 10, 293–295 (2013). https://doi.org/10.1007/s13770-013-1091-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13770-013-1091-z

Key words

Navigation